Document is current
Any future updates will be listed below
-
Authors
Federmann, Lydia M. https://orcid.org/0009-0006-4500-2175
David, Friederike S. https://orcid.org/0000-0001-9521-5669
Jockwitz, Christiane
Mühleisen, Thomas W. https://orcid.org/0000-0002-6057-5952
Pelzer, Dominique I. https://orcid.org/0000-0003-3360-5754
Nöthen, Markus M. https://orcid.org/0000-0002-8770-2464
Caspers, Svenja
Amunts, Katrin https://orcid.org/0000-0001-5828-0867
Goltermann, Janik
Andlauer, Till F. M. https://orcid.org/0000-0002-2917-5889
Stein, Frederike
Brosch, Katharina https://orcid.org/0000-0002-0526-8095
Kircher, Tilo
Cichon, Sven https://orcid.org/0000-0002-9475-086X
Dannlowski, Udo
Sindermann, Lisa
Forstner, Andreas J. https://orcid.org/0000-0002-1876-6368
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (NO 246/10-1)
Deutsche Forschungsgemeinschaft (NO 246/10-2)
Deutsche Forschungsgemeinschaft (KI588/14-1)
Deutsche Forschungsgemeinschaft (KI588/14-2)
Deutsche Forschungsgemeinschaft (KI588/20-1)
Deutsche Forschungsgemeinschaft (KI588/22-1)
Deutsche Forschungsgemeinschaft (DA1151/5-1)
Deutsche Forschungsgemeinschaft (DA1151/5-2)
- License Information
-
More Information
Article History
Received: 29 February 2024
Revised: 29 August 2024
Accepted: 13 September 2024
First Online: 2 October 2024
Competing interests
: TK reported receiving unrestricted educational grants from Servier, Janssen, Recordati, Aristo, Otsuka, and neuraxpharm. MMN reported receiving personal fees from Life&Brain GmbH that is not connected to this work. TFMA is a salaried employee of Boehringer Ingelheim Pharma outside the scope of the submitted work. No other disclosures were reported.
